Anti-apolipoprotein A-1 autoantibodies as biomarker for atherosclerosis burden in patients with periodontitis

Background and Objective Anti‐apolipoprotein A‐1 (anti‐apoA‐1) IgG is a potential marker of atherosclerotic plaque vulnerability and cardiovascular complications. In patients with periodontitis the presence of anti‐apoA‐1 IgGs in serum and their association with atherosclerosis is unknown. Material...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of periodontal research 2013-06, Vol.48 (3), p.350-356
Hauptverfasser: Wick, P. A., Mombelli, A., Pagano, S., Moren, X., Giannopoulou, C., Mach, F., Roux-Lombard, P., Vuilleumier, N.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background and Objective Anti‐apolipoprotein A‐1 (anti‐apoA‐1) IgG is a potential marker of atherosclerotic plaque vulnerability and cardiovascular complications. In patients with periodontitis the presence of anti‐apoA‐1 IgGs in serum and their association with atherosclerosis is unknown. Material and Methods One‐hundred and thirty subjects with periodontal disease and 46 healthy subjects, matched for age and gender, participated in this study. Anti‐apoA‐1 IgG, high‐sensitivity C‐reactive protein (hsCRP) and matrix metalloproteinase (MMP) ‐2, ‐3, ‐8 and ‐9 were measured in serum samples. An ankle‐brachial index (ABI) value below 1.11 served as a surrogate marker of atherosclerosis. Predictive accuracies of biomarkers for abnormal ABI were determined using receiver–operating characteristics curves and logistic regression analyses. Results Compared with healthy controls, periodontitis patients showed lower median ABI values (1.10 vs. 1.15; p 
ISSN:0022-3484
1600-0765
DOI:10.1111/jre.12014